Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis

Strahlentherapie und Onkologie

Volumn 190, Issue 9, 2014, Pages 839-846

  Arenz, Andrea ^a   Ziemann, Frank ^a   Mayer, Christina ^b   Wittig, Andrea ^a   Dreffke, Kirstin ^a   Preising, Stefanie ^a   Wagner, Steffen ^b   Klussmann, Jens Peter ^b   Engenhart Cabillic, Rita ^a   Wittekindt, Claus ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

DNA damage repair; Head and neck cancer; HPV related oropharyngeal cancer; Radiosensitivity

Indexed keywords

DOUBLE STRANDED DNA; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL LINE; CASE REPORT; CELL CYCLE CHECKPOINT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL GROWTH; CELL SURVIVAL; CLONOGENESIS; DNA DAMAGE; DNA REPAIR; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; OROPHARYNX CANCER; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; VERY ELDERLY; WART VIRUS;

ADULT; AGED; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; COLONY-FORMING UNITS ASSAY; DNA FRAGMENTATION; DNA REPAIR; FEMALE; FLOW CYTOMETRY; HISTONES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; TUMOR CELLS, CULTURED;

EID: 84906935543     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-014-0605-5     Document Type: Article

References (43)

1. Mehanna H, Beech T, Nicholson T et al (2013) Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 35:747-755
2. Mooren JJ, Kremer B, Claessen SM et al (2013) Chromosome stability in tonsillar squamous cell carcinoma is associated with HPV16 integration and indicates a favorable prognosis. Int J Cancer 132:1781-1789
3. Longworth MS, Laimins LA (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68:362-372 (Pubitemid 38756870)
4. Korzeniewski N, Spardy N, Duensing A et al (2011) Genomic instability and cancer: lessons learned from human papillomaviruses. Cancer Lett 305:113-122
5. Munger K, Howley PM (2002) Human papillomavirus immortalization and transformation functions. Virus Res 89:213-228 (Pubitemid 35351540)
6. Stubenrauch F, Laimins LA (1999) Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 9:379-386 (Pubitemid 30184507)
7. Duensing S, Munger K (2004) Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 109:157-162 (Pubitemid 38240914)
8. Pfister DG, Ang KK, Brizel DM et al (2011) Head and neck cancers. J Natl Compr Canc Netw 9:596-650
9. Dionysopoulos D, Pavlakis K, Kotoula V et al (2013) Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma. Strahlenther Onkol 189:202-214
10. Castro F, Dirks WG, Fahnrich S et al (2013) High-throughput SNP-based authentication of human cell lines. Int J Cancer 132:308-314
11. Ballo H, Koldovsky P, Hoffmann T et al (1999) Establishment and characterization of four cell lines derived from human head and neck squamous cell carcinomas for an autologous tumor-fibroblast in vitro model. Anticancer Res 19:3827-3836
12. Lansford CD, Grenman R, Bier H et al (1999) Head and neck cancers. In: Masters J, Palsson B, eds. Human cell culture cancer cell lines part 2. Kluwer Academic Press, Dordrecht, pp 185-255
13. Lin CJ, Grandis JR, Carey TE et al (2007) Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck 29:163-188 (Pubitemid 46167784)
14. Grenman R, Carey TE, McClatchey KD et al (1991) In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 67:2741-2747
15. Zhao M, Sano D, Pickering CR et al (2011) Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin Cancer Res 17:7248-7264
16. Friedman J, Nottingham L, Duggal P et al (2007) Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer. Clin Cancer Res 13:6568-6578 (Pubitemid 350206790)
17. Tang AL, Hauff SJ, Owen JH et al (2012) UMSCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line. Head Neck 34:1480-1491
18. White JS, Weissfeld JL, Ragin CC et al (2007) The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol 43:701-712 (Pubitemid 47058372)
19. Steenbergen RD, Hermsen MA, Walboomers JM et al (1995) Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 55:5465-5471
20. Wald AI, Hoskins EE, Wells SI et al (2011) Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 33:504-512
21. Rieckmann T, Tribius S, Grob TJ et al (2013) HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. Radiother Oncol 107(2):242-246
22. Franken NA, Rodermond HM, Stap J et al (2006) Clonogenic assay of cells in vitro. Nat Protoc 1:2315-2319
23. Deacon J, Peckham MJ, Steel GG (1984) The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol 2:317-323 (Pubitemid 15166542)
24. Balz V, Scheckenbach K, Gowosdz C, Bier H (eds) (2005) Current research in head and neck cancer. Molecular pathways, novel therapeutic targets, and prognostic factors. Karger, Basel
25. Yan B, Yang X, Lee TL et al (2007) Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma. Genome Biol 8:R78
26. Lee HO, Lee JH, Choi E et al (2006) A dominant negative form of p63 inhibits apoptosis in a p53-independent manner. Biochem Biophys Res Commun 344:166-172
27. Sano D, Xie TX, Ow TJ et al (2011) Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clin Cancer Res 17:6658-6670
28. Ehsanian R, Brown M, Lu H et al (2010) YAP dysregulation by phosphorylation or DeltaNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets. Oncogene 29:6160-6171
29. Gong J, Traganos F, Darzynkiewicz Z (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218:314-319 (Pubitemid 24141629)
30. Reimers N, Kasper HU, Weissenborn SJ et al (2007) Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 120:1731-1738 (Pubitemid 46399359)
31. Spanos WC, Nowicki P, Lee DW et al (2009) Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Arch Otolaryngol Head Neck Surg 135:1137-1146
32. Nagel RL, Martens-de Kemp SR, Buijze M et al (2013) Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines. Oral Oncol 49:560-566
33. Kimple RJ, Smith MA, Blitzer GC et al (2013) Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res 73:4791-4800
34. Gupta AK, Lee JH, Wilke WW et al (2009) Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT. Int J Radiat Oncol Biol Phys 74:928-933
35. Malaise EP, Deschavanne PJ, Fertil B (1989) The relationship between potentially lethal damage repair and intrinsic radiosensitivity of human cells. Int J Radiat Biol 56:597-604 (Pubitemid 20002004)
36. Ray D, Murphy KR, Gal S (2012) The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation. Cancer Biol Ther 13:848-857
37. Concin N, Zeillinger C, Stimpfel M et al (2000) p53-dependent radioresistance in ovarian carcinoma cell lines. Cancer Lett 150:191-199 (Pubitemid 30125854)
38. Skinner HD, Sandulache VC, Ow TJ et al (2012) TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence. Clin Cancer Res 18:290-300
39. Nguyen CL, Munger K (2008) Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes. Virology 380:21-25
40. Bedrosian I, Lee C, Tucker SL et al (2007) Cyclin E-associated kinase activity predicts response to platinum-based chemotherapy. Clin Cancer Res 13:4800-4806 (Pubitemid 47294787)
41. Leonce S, Perez V, Lambel S et al (2001) Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis. Mol Pharmacol 60:1383-1391 (Pubitemid 33144909)
42. Freije A, Ceballos L, Coisy M et al (2012) Cyclin E drives human keratinocyte growth into differentiation. Oncogene 31:5180-5192
43. Duensing S, Duensing A, Lee DC et al (2004) Cyclin-dependent kinase inhibitor indirubin-3′-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies. Oncogene 23:8206-8215 (Pubitemid 39531832)